Abstract
Older people are often especially susceptible to pneumonia and bacteria may develop resistance to antibiotics quicker in the elderly, whose immune systems gradually diminish. This study analyses, retrospectively, resistance to antibiotics in high-risk elderly patients with fatal pneumonia. Records of all patients aged over 65 who did not survive a bout with pneumonia were gathered from the records of the Department of Pneumology of HELIOS Clinic in Wuppertal, Germany from the period of 2004–2014. Susceptibility testing was executed for the study population, whose pneumonia was triggered by various kinds of bacteria. We detected 936 pneumonia patients of the overall mean age of 68.0 ± 13.6 years, with the following pneumonia types: 461 (49.3 %) community-acquired, 354 (37.8 %) nosocomial-acquired, and 121 (12.9 %) aspiration pneumonia. There were 631 (67.4 %) males and 305 (32.6 %) females there. We identified 672 (71.8 %) patients who had a high risk for pneumonia, especially staphylococcal pneumonia (p < 0.0001). The elderly patients had a higher risk of dying from pneumonia (2.9 odds ratio, 95 % confidence interval 1.8–4.6; p < 0.0001); of the 185 pneumonia-related deaths, 163 (88.1 %) were in the elderly. In those with fatal staphylococcal pneumonia, a high antibiotic resistance rate was found for piperacillin-tazobactam (p = 0.044), cefuroxime (p = 0.026), cefazolin (p = 0.043), levofloxacin (p = 0.018), erythromycin (p = 0.004), and clindamycin (p = 0.025). We conclude that elderly patients with staphylococcal pneumonia show resistance to common antibiotics. However, no significant antibiotic resistance could be ascribed for other types of pneumonia in these patients.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Barlett JG (1987) Diagnosis of bacterial infections of the lung. Clin Chest Med 8:119–134
Bauer AW, Kirby WM, Sherris JC, Turck M (1996) Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol 45:493–496
Chong CP, Street PR (2008) Pneumonia in the elderly: a review of severity assessment, prognosis, mortality, prevention, and treatment. South Med J 101(11):1134–1140
CLSI (2012) Clinical and Laboratory Standards Institute (2012) Performance standards for antimicrobial susceptibility testing. CLSI M100-S22. http://clsi.org/blog/2012/01/13/clsi-publishes-2012-antimicrobial-susceptibility-testing-standards/. Accessed 14 July 2015
Colakoğlu S, Alişkan H, Turunç T, Demiroğlu YZ, Arslan H (2008) Prevalence of inducible clindamycin resistance in Staphylococcus aureus strains isolated from clinical samples. Mikrobiyol Bul 42(3):407–412 (Article in Turkish)
Cunha BA (2001) Pneumonia in the elderly. Clin Microbiol Infect 7(11):581–588
Dikensoy O, Usalan C, Filiz A (2002) Foreign body aspiration: clinical utility of flexible bronchoscopy. Postgrad Med J 78(921):399–403
Donowitz GR, Cox HL (2007) Bacterial community-acquired pneumonia in older patients. Clin Geriatr Med 23(3):515–534
El-Solh AA, Sikka P, Ramadan F, Davies J (2001) Etiology of severe pneumonia in the very elderly. Am J Respir Crit Care Med 163(3 Pt 1):645–651
EUCAST (2011) European Committee on antimicrobial susceptibility testing breakpoints 2011–2014. http://www.eucast.org. Accessed 14 July 2015
Feikin DR, Schuchat A, Kolczak M et al (2000) Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995–1997. Am J Public Health 90(2):223–229
Feldman C (2001) Pneumonia in the elderly. Med Clin North Am 85(6):1441–1459
Gin A, Dilay L, Karlowsky JA, Walkty A, Rubinstein E, Zhanel GG (2007) Piperacillin-tazobactam: a beta-lactam/beta-lactamase inhibitor combination. Expert Rev Anti Infect Ther 5(3):365–383
Guay D (2007) Update on clindamycin in the management of bacterial, fungal and protozoal infections. Expert Opin Pharmacother 8(14):2401–2444
Gutiérrez F, Masiá M, Mirete C, Soldán B, Rodríguez JC, Padilla S, Hernández I, Royo G, Martin-Hidalgo A (2006) The influence of age and gender on the population-based incidence of community-acquired pneumonia caused by different microbial pathogens. J Infect 53(3):166–174
Hashemi SH, Soozanchi G, Jamal-Omidi S, Yousefi-Mashouf R, Mamani M, Seif-Rabiei MA (2010) Bacterial aetiology and antimicrobial resistance of community-acquired pneumonia in the elderly and younger adults. Trop Doct 40(2):89–91
Hidalgo M, Reyes J, Cárdenas AM, Díaz L, Rincón S, Vanegas N, Díaz PL, Castañeda E, Arias CA (2008) Resistance profiles to fluoroquinolones in clinical isolates of Gram positive cocci. Biomedica 28(2):284–294 (Article in Spanish)
Jalil A, Niazi ID, Khan SU (2008) Evaluation of restoration of sensitivities of resistant Staphylococcus aureus isolates by using cefuroxime and clavulanic acid in combination. J Ayub Med Coll Abbottabad 20(2):28–30
Kader AA, Kumar A, Krishna A (2005) Induction of clindamycin resistance in erythromycin-resistant, clindamycin susceptible and methicillin-resistant clinical Staphylococcal isolates. Saudi Med J 26(12):1914–1917
Kim HB, Lee B, Jang HC, Kim SH, Kang CI, Choi YJ, Park SW, Kim BS, Kim EC, Oh MD, Choe KW (2004) A high frequency of macrolide-lincosamide-streptogramin resistance determinants in Staphylococcus aureus isolated in South Korea. Microb Drug Resist 10(3):248–254
Marik PE (2001) Aspiration pneumonitis and aspiration pneumonia. N Engl J Med 344(9):665–671
Marrie TJ (2000) Community-acquired pneumonia in the elderly. Clin Infect Dis 31(4):1066–1078
Millett ER, Quint JK, Smeeth L, Daniel RM, Thomas SL (2013) Incidence of community-acquired lower respiratory tract infections and pneumonia among older adults in the United Kingdom: a population-based study. PLoS One 8(9), e75131
Mukae H, Kawanami T, Yatera K, Yanagihara K, Yamamoto Y, Kakeya H, Tokimatsu I, Kadota J, Kohno S (2014) Efficacy and safety of levofloxacin in patients with bacterial pneumonia evaluated according to the new “Clinical evaluation methods for new antimicrobial agents to treat respiratory infections (Second Version)”. J Infect Chemother 20(7):417–422
Nasiri MI, Naqvi SB, Zaidi AA, Saeed R, Raza G (2013) Comparative study on resistant pattern of clinical isolates against levofloxacin and cefepime. Pak J Pharm Sci 26(2):415–419
Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD, Dean N et al (2001) Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 163:1730–1754
Pachon J, Prados MD, Capote F, Cuello JA, Garnacho J, Verano A (1990) Severe community-acquired pneumonia. Etiology, prognosis, and treatment. Am Rev Respir Dis 142(2):369–373
Pepersack T (2014) Specificities of pneumonia in geriatrics. Rev Med Brux 35(4):368–374 (Article in French)
Petrosillo N, Cataldo MA, Pea F (2015) Treatment options for community-acquired pneumonia in the elderly people. Expert Rev Anti Infect Ther 13(4):473–485
Piątkowska E, Piątkowski J, Przondo-Mordarska A (2012) The strongest resistance of Staphylococcus aureus to erythromycin is caused by decreasing uptake of the antibiotic into the cells. Cell Mol Biol Lett 17(4):633–645
Prabhu K, Rao S, Rao V (2011) Inducible clindamycin resistance in Staphylococcus aureus isolated from clinical samples. J Lab Phys 3(1):25–27
Riquelme OR, Riquelme OM, Rioseco ZML, Gómez MV, Cárdenas G, Torres C (2008) Community-acquired pneumonia in the elderly: clinical and nutritional aspects. Rev Med Chil 136(5):587–593 (Article in Spanish)
Schito GC (2006) The importance of the development of antibiotic resistance in Staphylococcus aureus. Clin Microbiol Infect 12(Suppl 1):3–8
Shoji T, Hirai Y, Osawa M, Totsuka K (2014) Cefazolin therapy for methicillin-susceptible Staphylococcus aureus bacteremia in Japan. J Infect Chemother 20(3):175–180
Skov R, Frimodt-Møller N, Espersen F (2002) In vitro susceptibility of Staphylococcus aureus towards amoxycillin-clavulanic acid, penicillin-clavulanic acid, dicloxacillin and cefuroxime. APMIS 110(7–8):559–564
Watkins RR, Lemonovich TL (2011) Diagnosis and management of community-acquired pneumonia in adults. Am Fam Physician 83:1299–1306
WHO (2015) International Classification of Diseases (ICD). http://www.who.int/classification/icd/en/. Accessed 6 June 2015
Yilmaz G, Aydin K, Iskender S, Caylan R, Koksal I (2007) Detection and prevalence of inducible clindamycin resistance in staphylococci. J Med Microbiol 56(Pt 3):342–345
Ying L, Tang D (2010) Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics. Curr Top Med Chem 10(14):1441–1449
Conflicts of Interests
The authors declare no competing financial or otherwise interests in relation to this study.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Yayan, J., Rasche, K. (2015). Growing Antibiotic Resistance in Fatal Cases of Staphylococcal Pneumonia in the Elderly. In: Pokorski, M. (eds) Respiratory Contagion. Advances in Experimental Medicine and Biology(), vol 905. Springer, Cham. https://doi.org/10.1007/5584_2015_184
Download citation
DOI: https://doi.org/10.1007/5584_2015_184
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-30603-2
Online ISBN: 978-3-319-30604-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)